Europe Diltiazem Market Growth and Forecast by 2028

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028

Europe Diltiazem Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Capsules, Injection, and Tablets) and Application (Angina, Hypertension, and Others)

Report Date : Oct 2021
Report Code : TIPRE00025366

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 126

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Europe diltiazem market is expected to reach US$ 207.38 million by 2028 from US$ 95.08 million in 2021; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028.

Rise in government initiatives for promotion, increase in the prevalence of cardiovascular diseases, and rise in the elderly population with heart diseases worldwide are expected to boost the market growth over the years. However, side effects of diltiazem on consumption are likely to negatively impact the growth of the market in the coming years.

Heart diseases are primarily observed in older adults due to their weak immunity and other major health problems. According to the Global Ageing 2019 survey, the world's population of 65 and above totaled 703 million in 2019. The elderly demographic is expected to double to 1.5 billion people by 2050. This demographic is more susceptible to Cardiovascular dieseses (CVDs) such as arrhythmias. The elderly population is more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. Structural and functional changes in the cardiovascular system associated with aging are major causes of cardiovascular diseases. Therefore, the rising geriatric population worldwide is leading to an increase in the incidence of cardiovascular disease, bolstering the growth of the diltiazem market. Also, the diltiazem market is characterized by the presence of various small and big companies. The market players adopt new product launches, regional expansions, and product approvals to increase their market share. The players are investing in R&D to develop advanced technologies and gain significant revenue share in Europe. For instance, in March 2021, Glenmark Pharmaceuticals was granted competitive generic therapy (CGT) designation for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg; therefore, it is eligible for 180 days of CGT exclusivity upon commercial marketing. Thus, such recent developments are expected to act as a future trend in the diltiazem market

The European market is severely hit due to the exponential increase of COVID-19 cases in the region. The rising rate of COVID-19 is resulting in increased stress on the region's healthcare system, increasing the need for diagnostic tests in its healthcare system, encouraging the expansion of the sector in this region. Hypertension has been recorded in various cases and retrospective groups as a possible risk factor for the frequency and severity of COVID-19. Since the SARS-CoV-2's high infectivity rates, a possible interaction between COVID-19 and hypertension is worrisome. Diltiazem may be helpful to treat hypertension associated with COVID-19. Overall, diltiazem plays dual effects on hypertension-linked COVID-19 treatment by lowering high blood pressure and restraining NF-kb signaling pathway-related inflammation. The region witnessed some shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries. Market players and end users lost their business due to the temporarily shutting down of industries in various regions. However, the diltiazem market witnessed growth during the pandemic as it is anticipated to inhibit viral growth and related hypertension.
25047-img1

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE DILTIAZEM MARKET SEGMENTATION

By Product Type

Tablet
Capsules
Injection

By Application

Hypertension
Angina
Others

By Country

Italy
Germany
Spain
France
UK
Rest of Europe

Company Profiles

Bausch Health Companies Inc.
Teva Pharmaceutical Industries Ltd
MYLAN N.V.
Pfizer Inc.
Sandoz (Novartis AG)
Sun Pharmaceutical Industries Ltd
Hikma Pharmaceuticals PLC
Zydus Cadila
Glenmark

Europe Diltiazem Report Scope

Report Attribute	Details
Market size in 2021	US$ 95.08 Million
Market Size by 2028	US$ 207.38 Million
Global CAGR (2021 - 2028)	11.8%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Product Type Capsules Injection Tablets By Application Angina Hypertension
Regions and Countries Covered	Europe UK Germany France Russia Italy Rest of Europe
Market leaders and key company profiles	Bausch Health Companies Inc. Teva Pharmaceutical Industries Ltd MYLAN N.V. Pfizer Inc. Sandoz (Novartis AG) Sun Pharmaceutical Industries Ltd Hikma Pharmaceuticals PLC Zydus Cadila Glenmark

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Europe Diltiazem Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Europe Diltiazem Market Report Snapshots

Our Top Trending Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, Market Research

The research report delivered details on drivers and restraints, trends, and opportunities, along with strategic activities in the market. Previously, we were struggling to get reliable information.

Manager Medical Devices Manufacturing

Reason to Buy

Informed Decision-Making
Understanding Market Dynamics
Competitive Analysis
Identifying Emerging Markets

Customer Insights
Market Forecasts
Risk Mitigation
Boosting Operational Efficiency

Strategic Planning
Investment Justification
Tracking Industry Innovations
Aligning with Regulatory Trends

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

Is there support available if I can’t access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

Buy Now

87-673-9708

ISO 9001:2015